Mu‐opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic–pituitary–adrenal axis adrenocorticotropic hormone stress response to metyrapone
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The mu‐opioid receptor encoded by the gene OPRM1 plays a primary role in opiate, alcohol, cocaine and nicotine addiction. Studies using opioid antagonists demonstrate that the mu‐opioid receptor (MOP‐r) also mediates the hypothalamic–pituitary–adrenal (HPA) axis stress response. A common polymorphism in exon one of the MOP‐r gene, A118G, has been shown to significantly alter receptor function and MOP‐r gene expression; therefore, this variant likely affects HPA‐axis responsivity. In the current study, we have investigated whether the presence of the 118AG variant genotype affects HPA axis responsivity to the stressor metyrapone, which transiently blocks glucocorticoid production in the adrenal cortex. Forty‐eight normal and healthy volunteers (32 men, 16 women) were studied, among whom nine men and seven women had the 118AG genotype. The 118G allele blunted the adrenocorticotropic hormone (ACTH) response to metyrapone. Although there was no difference in basal levels of ACTH, subjects with the 118AG genotype had a more modest rise and resultant significantly lower ACTH levels than those with the prototype 118AA at the 8‐hour time point (P < 0.02). We found no significant difference between genders. These findings suggest a relatively greater tonic inhibition at hypothalamic–pituitary sites through the mu‐opioid receptor and relatively less cyclical glucocorticoid inhibition in subjects with the 118G allele.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stress and disorders of the stress system
Chrousos, G. P. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.106 · Cited by 3,215 · cited 1×
“The HPA axis responds to physiological and psychosocial stressors, and chronic HPA axis dysregulation has been shown to contribute to numerous medical disorders (e.g. Chrousos 2009).”
BackgroundTwenty-four hour pattern of the episodic secretion of cortisol in normal subjects
WEITZMAN, E. D., FUKUSHIMA, D., NOGEIRE, C., ROFFWARG, H., GALLAGHER, T. F., & HELLMAN, L. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-1-14 · Cited by 1,258
Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571 · cited 1×
“…have shown that naltrexone pharmacotherapy in alcoholdependent persons is more likely to be effective in persons with the 118G variant allele (Oslin et al. 2003; Anton et al. 2008) A recent study identified an increase in the neurosteroid allopregnanolone after naltrexone administration in…”
BackgroundAllelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G
Zhang, Y., Wang, D., Johnson, A. D., Papp, A. C., & Sadée, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504942200 · Cited by 563
Anton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.2.135 · Cited by 451 · cited 1×
“…naltrexone pharmacotherapy in alcoholdependent persons is more likely to be effective in persons with the 118G variant allele (Oslin et al. 2003; Anton et al. 2008) A recent study identified an increase in the neurosteroid allopregnanolone after naltrexone administration in subjects with one or…”
BackgroundGender differences in hypothalamic–pituitary–adrenal (HPA) axis reactivity
Uhart, M., Chong, R. Y., Oswald, L., Lin, P.-I., & Wand, G. S. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.02.003 · Cited by 274 · cited 2×
“There have been reports of gender differences in HPA axis reactivity within normal, healthy volunteers (Uhart et al. 2006), as well as in ACTH response to metyrapone”
BackgroundMedical safety and side effects of methadone in tolerant individuals
Kreek, M. J. (1973) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1973.03220060039009 · Cited by 247 · cited 1×
“Research conducted in our institution has documented that the HPA axis stress response to metyrapone in former heroin-dependent subjects has stabilized on methadone pharmacotherapy (Kreek 1973; Kreek et al. 1984; Schluger et al. 2001).”
BackgroundSelf-citationKroslak, T., LaForge, K. S., Gianotti, R. J., Ho, A., Nielsen, D. A., & Kreek, M. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04738.x · Cited by 213 · cited 2×
“…activation of G-protein-coupled potassium channels; (b) and increased receptor-binding affinity for beta-endorphin, but not for the other endogenous or exogenous opioid ligands; and (c) a reduced expression of the mu-opioid receptor on cell surfaces (Bond et al. 1998; Kroslak et al. 2007).”
BackgroundSelf-citationKreek, M., Ragunath, J., Plevy, S., Hamer, D., Schneider, B., & Hartman, N. (1984) · Neuropeptides · doi:10.1016/0143-4179(84)90081-7 · Cited by 97
Self-citationZhou, Y., Proudnikov, D., Yuferov, V., & Kreek, M. J. (2010) · Brain Research · doi:10.1016/j.brainres.2009.11.015 · Cited by 58
Self-citation
Cited by
Molecular mechanisms of opioid receptor-dependent signaling and behavior
Al-Hasani, R., & Bruchas, M. R. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318238bba6 · Cited by 1,067
MECHANISMS OF ENDOCRINOLOGY: endocrinology of opioids
Fountas, A., Chai, S. T., Kourkouti, C., & Karavitaki, N. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0270 · Cited by 60
Opioid endocrinopathy: a clinical problem in patients with cancer pain
MERDIN, A., MERDIN, F. A., GÜNDÜZ, Ş., BOZCUK, H., & COŞKUN, H. Ş. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3156 · Cited by 32
“The mechanisms underlying this interference are unknown, but it has been hypothesized that opioids inhibit the HPA axis via the µ -opioid receptor (7).”
Adrenal insufficiency in HIV/AIDS: a review
Mifsud, S., Gauci, Z., Gruppetta, M., Mallia Azzopardi, C., & Fava, S. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1979393 · Cited by 19
Metadata
- Authors
- Ducat, E., Ray, B., Bart, G., Umemura, Y., Varon, J., Ho, A., & Kreek, M. J.
- Venue
- Addiction Biology
- Publisher
- Wiley
- Published
- 2011-04-20
- Volume
- 18
- Issue
- 2
- Pages
- 325-331
- ISSN
- 1355-6215 (ISSN-L)
- 1369-1600
- OpenAlex
- W1931216733
- Cited by
- 37
- References
- 12
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mu‐opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic–pituitary–adrenal axis adrenocorticotropic hormone stress response to metyrapone. https://app.cochat.ai/papers/10.1111/j.1369-1600.2011.00313.x
- The paper
- Ducat, E., Ray, B., Bart, G., Umemura, Y., Varon, J., Ho, A., & Kreek, M. J. (2013). Mu‐opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic–pituitary–adrenal axis adrenocorticotropic hormone stress response to metyrapone. Addiction Biology. https://doi.org/10.1111/j.1369-1600.2011.00313.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.